Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription


1 AIDS Patient Care STDS
1 Am J Pathol
1 Arch Gynecol Obstet
1 Biochem Genet
1 Biochim Biophys Acta Mol Basis Dis
1 Biology (Basel)
1 BMC Cancer
1 BMC Prim Care
2 BMC Public Health
1 BMC Womens Health
2 BMJ Open
1 Br J Cancer
1 Brachytherapy
3 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Imaging
1 Cancer Manag Res
1 Cancer Rep (Hoboken)
1 Cell Mol Biol (Noisy-le-grand)
1 Cells
1 Chin Clin Oncol
2 Clin Cancer Res
1 Clin Epigenetics
1 Diseases
1 Dtsch Arztebl Int
1 Eur J Surg Oncol
1 Front Oncol
1 Gynecol Obstet Invest
2 Heliyon
1 Histopathology
1 Infect Agent Cancer
1 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
1 Int J Gynecol Pathol
1 Int J Public Health
1 Int J Womens Health
1 Int Rev Cell Mol Biol
1 J Cell Mol Med
1 J Clin Pathol
1 J Eur Acad Dermatol Venereol
1 J Low Genit Tract Dis
1 J Minim Invasive Gynecol
1 J Mol Biol
1 J Thromb Thrombolysis
1 JAMA Oncol
1 Lab Invest
2 LGBT Health
1 Maturitas
1 Mol Biol Rep
1 Pan Afr Med J
1 Pathol Res Pract
1 Phys Eng Sci Med
1 PLOS Glob Public Health
4 PLoS One
1 Radiat Prot Dosimetry
1 Saudi Med J
1 Virol J
1 World J Clin Cases
1 World J Surg Oncol
2 Zhonghua Fu Chan Ke Za Zhi
1 Zhonghua Nan Ke Xue
1 Zhonghua Zhong Liu Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AIDS Patient Care STDS

  1. FIRNHABER C, Simoncini G, Mayer C, Armon C, et al
    Mammogram and Pap Smear Uptake Among Women in the HIV Outpatient Study USA, 2010-2021.
    AIDS Patient Care STDS. 2024;38:151-154.

    Am J Pathol

  2. LIU Q, Zhang X, Jiang X, Zhang C, et al
    A Histopathologic Image Analysis for the Classification of Endocervical Adenocarcinoma Silva Patterns Depend on Weakly Supervised Deep Learning.
    Am J Pathol. 2024;194:735-746.
    PubMed         Abstract available

    Arch Gynecol Obstet

  3. SCHMITT F, Najjari L, Kupec T, Stickeler E, et al
    Predictors of significant distress in cervical cancer patients: a cross sectional study.
    Arch Gynecol Obstet. 2024 Apr 23. doi: 10.1007/s00404-024-07505.
    PubMed         Abstract available

    Biochem Genet

  4. HE H, Lin C, Lu Y, Wu H, et al
    Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating PTEN/PI3K/AKT Signaling Pathway.
    Biochem Genet. 2024;62:1277-1290.
    PubMed         Abstract available

    Biochim Biophys Acta Mol Basis Dis

  5. LI C, Xue Y, Wu J, Zhang L, et al
    MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos.
    Biochim Biophys Acta Mol Basis Dis. 2024 Apr 22:167190.
    PubMed         Abstract available

    Biology (Basel)

  6. HUANG L, Zhang J, Songyang Z, Xiong Y, et al
    Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer.
    Biology (Basel). 2024;13:227.
    PubMed         Abstract available


  7. CALVEZ J, Neirynck V, Marcelin AG, Jary A, et al
    Extending vaccination periods against human papillomavirus: Lessons from the SARS-CoV-2 pandemic.
    BJOG. 2024;131:877-879.

    BMC Cancer

  8. ADAM JA, Poel E, van Eck Smit BLF, Mom CH, et al
    [(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
    BMC Cancer. 2024;24:513.
    PubMed         Abstract available

    BMC Prim Care

  9. BONGAERTS THG, Buchner FL, Nierkens V, Crone MR, et al
    Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.
    BMC Prim Care. 2024;25:129.
    PubMed         Abstract available

    BMC Public Health

  10. HOUPERT R, Bendiane MK, Huiart L, Bouhnik AD, et al
    Socioeconomic and cultural factors associated with pap smear screening among French women living in Reunion Island.
    BMC Public Health. 2024;24:1125.
    PubMed         Abstract available

  11. NGU SF, Lau LS, Chan CY, Ngan HY, et al
    Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes.
    BMC Public Health. 2024;24:1104.
    PubMed         Abstract available

    BMC Womens Health

  12. ATIASE Y, Effah K, Mawusi Wormenor C, Tekpor E, et al
    Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    BMC Womens Health. 2024;24:260.
    PubMed         Abstract available

    BMJ Open

  13. BALOGUN FM, Omotade O
    Pursuance of a Yoruba name for cervical cancer in Southwest Nigeria: a case study.
    BMJ Open. 2024;14:e074020.
    PubMed         Abstract available

  14. ABDUL-LATIF M, Chowdhury A, Tharmalingam H, Taylor NJ, et al
    Exploratory study of using Magnetic resonance Prognostic Imaging markers for Radiotherapy In Cervix cancer (EMPIRIC): a prospective cohort study protocol.
    BMJ Open. 2024;14:e077390.
    PubMed         Abstract available

    Br J Cancer

  15. PORTNOY A, Pedersen K, Kim JJ, Burger EA, et al
    Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02682.
    PubMed         Abstract available


  16. SARWAR A, Eminowicz G
    Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence.
    Brachytherapy. 2024 Apr 19:S1538-4721(24)00044.
    PubMed         Abstract available


  17. DUSKA LR, Podwika SE, Randall LM
    Top advances of the year: Cervical cancer.
    Cancer. 2024 Apr 23. doi: 10.1002/cncr.35334.
    PubMed         Abstract available

  18. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.

  19. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.

    Cancer Epidemiol Biomarkers Prev

  20. CHENG D, Rieu-Werden ML, Lykken JM, Werner CL, et al
    Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed         Abstract available

    Cancer Imaging

  21. HUANG K, Huang X, Zeng C, Wang S, et al
    Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Cancer Imaging. 2024;24:54.
    PubMed         Abstract available

    Cancer Manag Res

  22. TESHOME R, Yang I, Woldetsadik E, Girma E, et al
    Pre- and Post-Treatment Quality of Life Among Patients with Advanced Stage Cervical Cancer at Tikur Anbessa Specialized Hospital, Ethiopia.
    Cancer Manag Res. 2024;16:311-323.
    PubMed         Abstract available

    Cancer Rep (Hoboken)

  23. HOSSEINI MS, Shafizadeh F, Bahremani MH, Farzaneh F, et al
    Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
    Cancer Rep (Hoboken). 2024;7:e2057.
    PubMed         Abstract available

    Cell Mol Biol (Noisy-le-grand)

  24. ZHENG L, Ren Q, Zhu W, Tao X, et al
    MiR-4319 targets tuftelin 1 to reduce malignancy of cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2024;70:54-60.
    PubMed         Abstract available


  25. MEHTA H, Ambele MA, Mokgautsi N, Moela P, et al
    Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
    Cells. 2024;13:700.
    PubMed         Abstract available

    Chin Clin Oncol

  26. LEE J, Lapuz C, Khor R, Lau E, et al
    Narrative review of the utility of magnetic resonance imaging in radiotherapy for cervical cancer.
    Chin Clin Oncol. 2024 Apr 13:cco-23-91. doi: 10.21037.
    PubMed         Abstract available

    Clin Cancer Res

  27. CHAMBERS L, Haight P, Chalif J, Mehra Y, et al
    Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research.
    Clin Cancer Res. 2024 Apr 25. doi: 10.1158/1078-0432.CCR-23-2570.
    PubMed         Abstract available

  28. SIVARS L, Jylha C, Crona Guterstam Y, Zupancic M, et al
    Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer.
    Clin Cancer Res. 2024 Apr 26. doi: 10.1158/1078-0432.CCR-23-3941.
    PubMed         Abstract available

    Clin Epigenetics

  29. FACKLER MJ, Pleas M, Li Y, Soni A, et al
    Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
    Clin Epigenetics. 2024;16:56.
    PubMed         Abstract available


  30. PETRE I, Vernic C, Petre I, Vlad CS, et al
    Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer.
    Diseases. 2024;12:77.
    PubMed         Abstract available

    Dtsch Arztebl Int

  31. GRIEGER P, Eisemann N, Hammersen F, Rudolph C, et al
    Initial Evidence of a Possible Effect of HPV Vaccination on Cancer Incidence in Germany-Focus on Cervical Cancer.
    Dtsch Arztebl Int. 2024;.
    PubMed         Abstract available

    Eur J Surg Oncol

  32. SABAH J, Menoux I, Eberst L, Lodi M, et al
    Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?
    Eur J Surg Oncol. 2024;50:108281.
    PubMed         Abstract available

    Front Oncol

  33. LIANG M, Sheng L, Ke Y, Wu Z, et al
    The research progress on radiation resistance of cervical cancer.
    Front Oncol. 2024;14:1380448.
    PubMed         Abstract available

    Gynecol Obstet Invest

  34. WANG Y, Wang H
    CCT6A regulates cervical cancer cell glycolysis and proliferation under hypoxic conditions via the TCAB1/TERT.
    Gynecol Obstet Invest. 2024 Apr 24. doi: 10.1159/000539042.
    PubMed         Abstract available


  35. MA CY, Zhao J, Zhou JY
    Microbiome profiling and Co-metabolism pathway analysis in cervical cancer patients with acute radiation enteritis.
    Heliyon. 2024;10:e29598.
    PubMed         Abstract available

  36. SCHLUETER D, Bermudez Y, Debrot KF, Ross LW, et al
    Breast and cervical cancer programs' success in maintaining screening during periods of high COVID-19: A qualitative multi-case study analysis.
    Heliyon. 2024;10:e29223.
    PubMed         Abstract available


  37. YASUTAKE N, Yamamoto H, Kuga R, Jiromaru R, et al
    Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Histopathology. 2024;84:1178-1191.
    PubMed         Abstract available

    Infect Agent Cancer

  38. ZHANG Y, Du H, Wang C, Huang X, et al
    Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial.
    Infect Agent Cancer. 2024;19:16.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  39. ALFAREH M, Obeid D, Alhoshan H, Basri R, et al
    Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey.
    Int J Gynaecol Obstet. 2024 Apr 19. doi: 10.1002/ijgo.15532.
    PubMed         Abstract available

    Int J Gynecol Cancer

  40. VAZQUEZ-VICENTE D, Boria F, Castellanos T, Gutierrez M, et al
    SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Int J Gynecol Cancer. 2024;34:203-208.
    PubMed         Abstract available

  41. CHARNALIA M, Chopra S, Mulani J, Popat P, et al
    RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336.
    PubMed         Abstract available

  42. ROSATI A, Certelli C, Ferrandina G, Fanfani F, et al
    Minimally invasive adrenalectomy: a personalized surgical approach in recurrent cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2023-005241.

    Int J Gynecol Pathol

  43. STOLNICU S, Praiss AM, Allison D, Tessier-Cloutier B, et al
    Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma.
    Int J Gynecol Pathol. 2024;43:203-214.
    PubMed         Abstract available

    Int J Public Health

  44. THOMAS-PURCELL K, Bailey A, Sealy DA, Song G, et al
    Cervical Cancer Stigma Among Caribbean Population: A Descriptive Paper.
    Int J Public Health. 2024;69:1606725.
    PubMed         Abstract available

    Int J Womens Health

  45. TESHOME R, Yang I, Woldetsadik E, Girma E, et al
    Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer.
    Int J Womens Health. 2024;16:605-617.
    PubMed         Abstract available

    Int Rev Cell Mol Biol

  46. AGARWAL M, Kumar M, Pathak R, Bala K, et al
    Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
    Int Rev Cell Mol Biol. 2024;385:227-261.
    PubMed         Abstract available

    J Cell Mol Med

  47. DATTA S, Verma P, Dhara B, Kundu R, et al
    Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid.
    J Cell Mol Med. 2024;28:e18302.
    PubMed         Abstract available

    J Clin Pathol

  48. LIU Q, Zhang T, Chen L, Zhou X, et al
    Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases.
    J Clin Pathol. 2023 Jan 18:jcp-2022-208580. doi: 10.1136/jcp-2022-208580.
    PubMed         Abstract available

    J Eur Acad Dermatol Venereol

  49. SKERLEV M, Ljubojevic Hadzavdic S, Sirotkovic-Skerlev M
    Not all bad with HPV is the cervical cancer only!
    J Eur Acad Dermatol Venereol. 2024;38:796-797.

    J Low Genit Tract Dis

  50. MOHAMMAD H, Espensen AS, Arnardottir MB, Bergholdt SH, et al
    The Incidence of Cervical Intraepithelial Neoplasia or Cervical Cancer in Women Referred With Postcoital Bleeding.
    J Low Genit Tract Dis. 2024 Apr 23. doi: 10.1097/LGT.0000000000000808.
    PubMed         Abstract available

    J Minim Invasive Gynecol

    vNOTES Radical Hysterectomy: A New Approach To Cervical Cancer.
    J Minim Invasive Gynecol. 2024 Apr 18:S1553-4650(24)00173.
    PubMed         Abstract available

    J Mol Biol

  52. BOLDINOVA EO, Baranovskiy AG, Filina YV, Miftakhova RR, et al
    PrimPol Variant V102A with Altered Primase and Polymerase Activities.
    J Mol Biol. 2024;436:168542.
    PubMed         Abstract available

    J Thromb Thrombolysis

  53. NETO BV, Tavares V, da Silva JB, Liz-Pimenta J, et al
    Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies.
    J Thromb Thrombolysis. 2024 Apr 20. doi: 10.1007/s11239-024-02983.
    PubMed         Abstract available

    JAMA Oncol

  54. CHO WK, Park W, Kim SW, Lee KK, et al
    Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer: The POHIM-CCRT Nonrandomized Controlled Trial.
    JAMA Oncol. 2024 Apr 25. doi: 10.1001/jamaoncol.2024.0565.
    PubMed         Abstract available

    Lab Invest

  55. ZHONG F, Wang T, Li W, Zhang H, et al
    Associations of Single Versus Multiple Human Papillomavirus Infections With the Prevalence of Cervical Intraepithelial Neoplasia 2/3 and Squamous Cell Carcinoma Lesions: Human Papillomavirus Type-Specific Attribution.
    Lab Invest. 2024;104:100328.
    PubMed         Abstract available

    LGBT Health

  56. FLEMING J, Grasso C, Mayer KH, Reisner SL, et al
    Gender-Affirming Hormone Therapy and Cervical Cancer Screening Rates in Transgender Men and Nonbinary People: A Cross-Sectional Study from a Boston Community Health Center.
    LGBT Health. 2024 Apr 26. doi: 10.1089/lgbt.2023.0418.
    PubMed         Abstract available

  57. MCDOWELL A, Rieu-Werden ML, Atlas SJ, Fields CD, et al
    Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
    LGBT Health. 2024 Apr 22. doi: 10.1089/lgbt.2023.0067.
    PubMed         Abstract available


  58. VAN DER HOEF C, Bawuah Dsane L, Schuur N, Louwers YV, et al
    Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study.
    Maturitas. 2024;185:108004.
    PubMed         Abstract available

    Mol Biol Rep

  59. DENG S, Yuan P, Sun J
    The role of NF-kappaB in carcinogenesis of cervical cancer: opportunities and challenges.
    Mol Biol Rep. 2024;51:538.
    PubMed         Abstract available

    Pan Afr Med J

  60. MAYERI DG, Kahasha PM, Kibalama IB, Mongane J, et al
    Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
    Pan Afr Med J. 2024;47:57.
    PubMed         Abstract available

    Pathol Res Pract

  61. YIN C, Yu J, Liu G, He J, et al
    Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer.
    Pathol Res Pract. 2024;257:155315.
    PubMed         Abstract available

    Phys Eng Sci Med

  62. LEUNG SN, Chandra SS, Lim K, Young T, et al
    Automatic segmentation of tumour and organs at risk in 3D MRI for cervical cancer radiation therapy with anatomical variations.
    Phys Eng Sci Med. 2024 Apr 24. doi: 10.1007/s13246-024-01415.
    PubMed         Abstract available

    PLOS Glob Public Health

  63. KHOJA L, Wang Y, Haque SE, Ahsan H, et al
    Understanding of cervical cancer, acceptability of HPV self-collection, and prevalence of HPV in a semi-urban setting in Bangladesh.
    PLOS Glob Public Health. 2024;4:e0003157.
    PubMed         Abstract available

    PLoS One

  64. TIRKASO BH, Bayisa TH, Desta TW
    Histopathologic patterns and factors associated with cervical lesions at Jimma Medical Center, Jimma, Southwest Ethiopia: A two-year cross-sectional study.
    PLoS One. 2024;19:e0301559.
    PubMed         Abstract available

  65. MOSHI JM, Ummelen M, Smedts F, Ramaekers FCS, et al
    Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
    PLoS One. 2024;19:e0297008.
    PubMed         Abstract available

  66. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    PubMed         Abstract available

  67. ZEBER-LUBECKA N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, et al
    Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
    PLoS One. 2024;19:e0302270.
    PubMed         Abstract available

    Radiat Prot Dosimetry

  68. PATODI V, Soni TP, Singh DK, Patni N, et al
    Dosimetric comparison of O-ring versus conventional C-arm linear accelerator for volumetric modulated arc therapy (VMAT) of head and neck cancer and carcinoma cervix patients.
    Radiat Prot Dosimetry. 2024;200:538-543.
    PubMed         Abstract available

    Saudi Med J

  69. What factors contribute to differences in cervical cancer screening in rural and urban community health centers?
    Saudi Med J. 2024;45:447.

    Virol J

  70. MA B, Zhou J, Zhou W, Ma Z, et al
    Nonlinear relationship between viral load and TCT in single/multiple HPV52 infection.
    Virol J. 2024;21:90.
    PubMed         Abstract available

    World J Clin Cases

  71. ALZIBDEH A, Mohamad I, Wahbeh L, Abuhijlih R, et al
    Can we triumph over locally advanced cervical cancer with colossal para-aortic lymph nodes? A case report.
    World J Clin Cases. 2024;12:1851-1856.
    PubMed         Abstract available

    World J Surg Oncol

  72. YUAN H, Li L, Li N, Yao H, et al
    Sarcoma of the uterine cervix: experience of a single center.
    World J Surg Oncol. 2024;22:104.
    PubMed         Abstract available

    Zhonghua Fu Chan Ke Za Zhi

  73. LI X, Gao YH, Yang Z, Ma Y, et al
    [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:307-319.
    PubMed         Abstract available

  74. ZHANG W, Cao YS, Wei MC, Xu J, et al
    [Application of optical coherence tomography in the evaluation of cervical lesions: a multicenter study].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:299-306.
    PubMed         Abstract available

    Zhonghua Nan Ke Xue

  75. ZHANG J, Shao SY, Ma YJ, Qin W, et al
    [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
    Zhonghua Nan Ke Xue. 2023;29:826-830.
    PubMed         Abstract available

    Zhonghua Zhong Liu Za Zhi

  76. [Specification for quality control of cervical cancer screening (DB11/T 2137-2023)].
    Zhonghua Zhong Liu Za Zhi. 2024;46:269-273.

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.